Browse Pet Safety Reports
969,382 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 969,382 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 969,382 FDA veterinary adverse event reports for Dog.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Mar 9, 2026 | Dog | Spaniel - King Charles Cava... | Moxidectin | Emesis (multiple); Itching; Head shake - ear disorder; Scooting; Reddening of... | Recovered/Normal |
| Mar 9, 2026 | Dog | Mixed (Dog) | Pyrantel Pamoate;Sarolaner | Skin lesion NOS; Histiocytoma; Hiding; Icterus; Tachycardia; Fever; Depressio... | Ongoing |
| Mar 9, 2026 | Dog | Terrier - Bull - American P... | Melarsomine Dihydrochloride | Intentional misuse; Facial swelling (see also Skin); Reddening of the skin; S... | Ongoing |
| Mar 9, 2026 | Dog | Spaniel - Cocker English | Fluralaner Powder For Inj Susp | Ataxia; Decreased packed cell volume (PCV); Spherocytosis; Leukocytosis NOS; ... | Ongoing |
| Mar 9, 2026 | Dog | Terrier (unspecified) | Moxidectin | Facial pruritus; Injection site pain | Ongoing |
| Mar 9, 2026 | Dog | Retriever - Labrador | Milbemycin/Lufenuron/Pzq Chew | Lack of efficacy (endoparasite) - roundworm NOS | Ongoing |
| Mar 9, 2026 | Dog | Crossbred Canine/dog | Grapiprant | Elevated alanine aminotransferase (ALT); Elevated serum alkaline phosphatase ... | Outcome Unknown |
| Mar 9, 2026 | Dog | Pit Bull | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Lack of efficacy (endoparasite) - roundworm NOS | Ongoing |
| Mar 9, 2026 | Dog | Whippet | Pyrantel Pamoate;Sarolaner | Bloodshot eye; Squinting; Strabismus; Eye disorder NOS (for Photophobia see n... | Outcome Unknown |
| Mar 9, 2026 | Dog | Dog (unknown) | Pimobendan | Anorexia | Recovered/Normal |
| Mar 9, 2026 | Dog | Cattle Dog - Australian (bl... | Bedinvetmab | Ataxia; Polyuria; Polydipsia; Vomiting; Elevated liver enzymes NOS; Medicatio... | Ongoing |
| Mar 9, 2026 | Dog | Spaniel - King Charles Cava... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia | Ongoing |
| Mar 9, 2026 | Dog | Beagle | Afoxolaner 37.5Mg / Moxidectin 180Mcg... | Lack of efficacy (endoparasite) - roundworm NOS | Outcome Unknown |
| Mar 9, 2026 | Dog | Rottweiler | Moxidectin | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Mar 9, 2026 | Dog | Schnauzer - Miniature, Dog ... | Alfaxalone | Bradycardia; Hypotension; Premature ventricular contractions; Hypoventilation... | Ongoing |
| Mar 9, 2026 | Dog | Poodle - Miniature, Spaniel... | Afoxolaner 9.375Mg / Moxidectin 45Mcg... | Lethargy (see also Central nervous system depression in Neurological); Ataxia... | Outcome Unknown |
| Mar 9, 2026 | Dog | Chihuahua, Terrier - Boston | Nitenpyram | Lack of efficacy (ectoparasite) - flea | Outcome Unknown |
| Mar 9, 2026 | Dog | Retriever - Golden | Bedinvetmab | Partial lack of efficacy | Ongoing |
| Mar 9, 2026 | Dog | Terrier - Yorkshire | Pyrantel Pamoate;Sarolaner | Vomiting | Recovered/Normal |
| Mar 9, 2026 | Dog | Chihuahua | Milbemycin Oxime; Praziquantel | Falling; Stumbling gait | Ongoing |
| Mar 9, 2026 | Dog | Poodle (unspecified), Spani... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia; Lack of efficacy (bacteria) - Anaplas... | Ongoing |
| Mar 9, 2026 | Dog | Retriever (unspecified) | Pyrantel Pamoate;Sarolaner | Vomiting | Recovered/Normal |
| Mar 9, 2026 | Dog | Shepherd Dog - Belgian Mali... | Melarsomine Dihydrochloride | Hypersalivation; Weakness; Obtunded; Reduced responses; Tachycardia; Hyperten... | Ongoing |
| Mar 9, 2026 | Dog | Spaniel (unspecified) | Sarolaner | Trembling; Ataxia | Ongoing |
| Mar 9, 2026 | Dog | Retriever - Labrador | Lotilaner,Moxidectin,Praziquantel,Pyr... | Lack of efficacy (bacteria) - Anaplasma | Outcome Unknown |
| Mar 9, 2026 | Dog | Spaniel - Cocker American | Ilunocitinib | Limping; Licking; Pain NOS; Hyperkeratosis; Bumps on skin; Local swelling (no... | Ongoing |
| Mar 9, 2026 | Dog | Spitz - German Pomeranian | Moxidectin | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Mar 9, 2026 | Dog | Boxer (German Boxer) | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Mar 9, 2026 | Dog | Collie - Border | Lotilaner,Moxidectin,Praziquantel,Pyr... | Not himself/herself; Gut sounds increased; Sleepiness - systemic disorder; No... | Ongoing |
| Mar 9, 2026 | Dog | Beagle | Pyrantel Pamoate;Sarolaner | Vomiting | Recovered/Normal |
| Mar 9, 2026 | Dog | Terrier - Bull - American Pit | Sarolaner | Lack of efficacy (bacteria) - Borrelia; Intentional misuse; Lack of efficacy ... | Ongoing |
| Mar 9, 2026 | Dog | Shepherd Dog - Australian, ... | Ilunocitinib | Gingival disorder | Ongoing |
| Mar 9, 2026 | Dog | Weimaraner, Dog (unknown) | Lotilaner,Moxidectin,Praziquantel,Pyr... | Diarrhoea | Recovered/Normal |
| Mar 9, 2026 | Dog | Crossbred Canine/dog | Fenbendazol Granules | Elevated blood urea nitrogen (BUN); Elevated alanine aminotransferase (ALT) | Outcome Unknown |
| Mar 9, 2026 | Dog | Siberian Husky | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Lack of efficacy (bacteria) - Anaplasma | Ongoing |
| Mar 9, 2026 | Dog | Shepherd Dog (unspecified) | Afoxolaner 18.75Mg / Moxidectin 90Mcg... | Lack of efficacy (bacteria) - Borrelia | Outcome Unknown |
| Mar 9, 2026 | Dog | Beagle | Melarsomine Dihydrochloride | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Mar 9, 2026 | Dog | Rottweiler, Dog (unknown) | Bedinvetmab | Lethargy (see also Central nervous system depression in Neurological); Decrea... | Recovered/Normal |
| Mar 9, 2026 | Dog | Spaniel - King Charles Cava... | Trilostane | Restlessness; Agitation; Panting; Drooling; Behavioural disorder NOS | Recovered/Normal |
| Mar 9, 2026 | Dog | Great Pyrenees | Afoxolaner 150Mg / Moxidectin 720Mcg ... | Lack of efficacy (endoparasite) - tapeworm | Outcome Unknown |
| Mar 9, 2026 | Dog | Retriever - Labrador | Spinosad; Milbemycin Oxime | Lack of efficacy (endoparasite) - heartworm; Drug dose omission | Outcome Unknown |
| Mar 9, 2026 | Dog | Retriever - Golden | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Mar 9, 2026 | Dog | Crossbred Canine/dog | Afoxolaner 18.75Mg / Moxidectin 90Mcg... | Lack of efficacy (ectoparasite) - flea | Outcome Unknown |
| Mar 9, 2026 | Dog | Cattle Dog (unspecified), D... | Lotilaner,Moxidectin,Praziquantel,Pyr... | Lack of efficacy (ectoparasite) - flea | Outcome Unknown |
| Mar 9, 2026 | Dog | Terrier (unspecified) | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Mar 9, 2026 | Dog | Bichon Frise | Bedinvetmab | Seizure NOS | Outcome Unknown |
| Mar 9, 2026 | Dog | Siberian Husky | Milbemycin/Lufenuron/Pzq Chew | Head tilt - neurological disorder (see also Head tilt - ear disorder); Not hi... | Recovered/Normal |
| Mar 9, 2026 | Dog | Shepherd (unspecified), Dog... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Mar 9, 2026 | Dog | Crossbred Canine/dog | Milbemycin/Lufenuron/Pzq Chew | Lack of efficacy (endoparasite) - roundworm NOS | Ongoing |
| Mar 9, 2026 | Dog | Dog (unknown) | Fluralaner 13.64% 12-Week Chew | Sleepiness - systemic disorder | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.